Clinicopathological parameters | N | Â | ECM1 expression | Â | LMVD | Â |
---|---|---|---|---|---|---|
- | + | P | (LMV per × 200 field) | P | ||
Gender | Â | Â | Â | 0.618 | Â | 0.627 |
Male | 47 | 13 | 34 |  | 7.76 ± 1.21 |  |
Female | 30 | 10 | 20 |  | 7.83 ± 1.23 |  |
Age (years) | Â | Â | Â | 0.628 | Â | 0.553 |
<60 | 37 | 10 | 27 |  | 7.25 ± 1.17 |  |
≥60 | 40 | 13 | 27 |  | 8.34 ± 1.33 |  |
Differentiation degree | Â | Â | Â | 0.489 | Â | 0.253 |
Low | 36 | 11 | 25 |  | 9.25 ± 1.37 |  |
Moderate | 23 | 5 | 18 |  | 5.75 ± 1.22 |  |
Well | 18 | 7 | 11 |  | 7.94 ± 2.01 |  |
Depth of invasion | Â | Â | Â | <0.0001*** | Â | 0.721 |
T1-T2 | 23 | 18 | 5 |  | 8.77 ± 1.97 |  |
T3-T4 | 54 | 5 | 49 |  | 7.53 ± 0.99 |  |
Lymph node metastasis | Â | Â | Â | 0.521 | Â | 0.110 |
0 | 34 | 9 | 25 |  | 6.74 ± 1.29 |  |
1-2 | 18 | 9 | 11 |  | 7.00 ± 2.46 |  |
3-6 | 10 | 3 | 7 |  | 11.00 ± 2.74 |  |
≥7 | 15 | 4 | 11 |  | 9.57 ± 1.47 |  |
TNM stage | Â | Â | Â | 0.0014** | Â | 0.241 |
0-I | 21 | 12 | 9 |  | 8.50 ± 2.12 |  |
II-III | 27 | 11 | 45 |  | 8.67 ± 1.18 |  |